SOUTH SAN FRANCISCO, CA--(Marketwire - January 07, 2008) - CoMentis, Inc., a privately held biopharmaceutical company, announced today that John L. Higgins has joined the company’s Board of Directors. Mr. Higgins is President, Chief Executive Officer and a member of the Board of Directors of Ligand Pharmaceuticals, Inc. (NASDAQ: LGND).
